SeaStar Medical (ICU) CEO awarded 30,000 RSUs of common stock

Rhea-AI Filing Summary

SeaStar Medical Holding Corp disclosed that its Chief Executive Officer, Eric Schlorff, received an award of 30,000 shares of common stock in the form of restricted stock units on February 6, 2026, at a grant price of $0 per share.

The RSU award vests in three equal installments on the first, second and third anniversaries of February 6, 2026. Following this grant, Schlorff beneficially owned 39,852 shares of SeaStar Medical common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schlorff Eric

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.0001	30,000	$0.00	--

Holdings After Transaction: Common Stock, par value $0.0001 — 39,852 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schlorff Eric

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER C0 80216

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	02/06/2026		A		30,000(1)	A	$0	39,852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an RSU award. The RSU award vests in equal installments on the first, second and third anniversaries of February 6, 2026

	/s/ Eric Schlorff	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ICU report for CEO Eric Schlorff?

SeaStar Medical reported that CEO Eric Schlorff received 30,000 restricted stock units of common stock on February 6, 2026, at a grant price of $0 per share. This equity award increased his directly held beneficial ownership to 39,852 common shares.

How many SeaStar Medical (ICU) shares does the CEO own after this award?

After the February 6, 2026 RSU grant, CEO Eric Schlorff beneficially owned 39,852 shares of SeaStar Medical common stock. This figure reflects his direct ownership following the 30,000-share restricted stock unit award reported in the Form 4 filing.

What are the vesting terms of the 30,000 RSUs granted to ICUs CEO?

The 30,000 restricted stock units granted to SeaStar Medicals CEO vest in three equal installments. They vest on the first, second, and third anniversaries of February 6, 2026, meaning the award is spread evenly over a three-year period.

Was any cash paid for the RSUs granted to the SeaStar Medical CEO?

No cash was paid for this equity award. The Form 4 shows a transaction price of $0 per share for the 30,000 restricted stock units of SeaStar Medical common stock granted to CEO Eric Schlorff on February 6, 2026.

Is the ICU CEOs reported ownership held directly or indirectly?

The filing shows that CEO Eric Schlorffs 39,852 shares of SeaStar Medical common stock are held directly. The ownership form is listed as D for direct, and no indirect ownership entity or nature of indirect beneficial ownership is specified.